Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A

Clinical Therapeutics

Volumn 28, Issue 2, 2006, Pages 251-254

  Gül, Ülker ^a   Gönül, Müzeyyen ^a   Kiliç, Arzu ^a   Erdem, Rana ^a   Çakmak, Seray Külcü ^a   Gündüz, Hülya ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

etanercept; psoriatic arthritis; tumor necrosis factor blockers

Indexed keywords

ANTISTREPTOLYSIN; C REACTIVE PROTEIN; CYCLOSPORIN A; ELECTROLYTE; ETANERCEPT; GLUCOSE; INDOMETACIN; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR MARKER;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ANKYLOSIS; ANTIBODY BLOOD LEVEL; ARTHRALGIA; ARTICLE; BACK; BODY SURFACE; BONE ATROPHY; CASE REPORT; DESQUAMATION; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; ERYTHRODERMA; ESOPHAGOGASTRODUODENOSCOPY; FOOT; FOOT DISEASE; GLUCOSE BLOOD LEVEL; HAND; HAND DISEASE; HIATUS HERNIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERPHALANGEAL JOINT; JOINT FUNCTION; JOINT LIMITATION; JOINT SWELLING; KIDNEY FUNCTION; LABORATORY TEST; LIVER FUNCTION; LUMBAR VERTEBRA; MALE; MORNING STIFFNESS; MUSCLE SPASM; NAIL; NAUSEA AND VOMITING; PAIN; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; PROXIMAL INTERPHALANGEAL JOINT; PSORIASIS; PSORIATIC ARTHRITIS; RADIODIAGNOSIS; RASH; SACROILIAC JOINT; SACROILIITIS; SPINE MOBILITY; SUPPOSITORY; THORAX; URINALYSIS; VISUAL ANALOG SCALE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOGLOBULIN G; INFUSIONS, PARENTERAL; MALE; METHOTREXATE; RECEPTORS, TUMOR NECROSIS FACTOR; SUPPOSITORIES;

EID: 33646203408     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.02.002     Document Type: Article

References (13)

1. Gottlieb A. Etanercept for the treatment of psoriasis and psoriatic arthritis. Dermatol Ther. 17 (2004) 401-408
2. Mease P., Kivitz A., Burch F., et al. Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression. Arthritis Rheum 50 (2004) 2264-2272
3. Magliocco M., and Gottlieb A. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases. J Am Acad Dermatol 51 (2004) 580-584
4. Moder K., and Hunder G. Examination of the joints. In: Ruddy S., Harris Jr. E., and Sledge C. (Eds). Kelley's Textbook of Rheumatology. 6th ed. (2001), WB Saunders, Philadelphia, Pa 347-365
5. Pincus T., Amara I., and Koch G. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: Lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum 52 (2005) 1031-1036
6. Winchester R. Psoriatic arthritis. In: Freedberg I., Eisen A., Wolff K., et al. (Eds). Dermatology in General Medicine. 6th ed. (2003), McGraw-Hill, New York, NY 427-436
7. Espinoza L., Zakraoui L., Espinoza C., et al. Psoriatic arthritis: Clinical response and side effects to methotrexate therapy. J Rheumatol 19 (1992) 872-877
8. Costanzo A., Mazotta A., Papoutsaki M., et al. Safety and efficacy study on etanercept in patients with plaque psoriasis. Br J Dermatol. 152 (2005) 187-189
9. Mease P., Ritchlin C., Martin R., et al. Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. J Rheumatol 31 (2004) 1356-1361
10. Mease P. TNFalpha therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 63 (2004) 755-758
11. Strober B. Successful treatment of psoriasis and psoriatic arthritis with etanercept and methotrexate in a patient newly unresponsive to infliximab. Arch Dermatol 140 (2004) 366
12. Cohen R., Tsang J., and Hanauer S. Infliximab in Crohn's disease: First anniversary clinical experience. Am J Gastroenterol 95 (2000) 3469-3477
13. Maini R., Breedveld F., Kalden J., et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41 (1998) 1552-1563